FAST NEWS: Venus Medtech’s loss narrows on surging overseas sales
The latest: Medical device maker Venus Medtech (Hangzhou) Inc. (2500.HK) reported last Thursday its net loss narrowed 31.8% last year to 721 million yuan ($99.7 million). Looking up: The company’s annual revenue…
Lacking Revenue, Jenscare Scientific Hopes IPO Investors Take Heart in Its Potential
The maker of devices to treat structural heart disease hopes to have its first product approved in the second half of next year as it prepares to list in Hong…
RELATED ARTICLES
-
Venus Medtech still seeking cure for governance problems
2500.HK -
FAST NEWS: PW Medtech’s profit jumps on post-Covid rebound
1358.HK
-
Rebounding Perfect Medical finds beauty safe haven in Hong Kong
1830.HK
- Medical imaging group Rimag sets growth focus with IPO
-
MedBot seeks commercial edge with dual-use surgical robot
2252.HK
- Malo Medical pitches IPO to help fill China’s dentistry gap
